236 related articles for article (PubMed ID: 27609457)
21. Honokiol targets mitochondria to halt cancer progression and metastasis.
Pan J; Lee Y; Wang Y; You M
Mol Nutr Food Res; 2016 Jun; 60(6):1383-95. PubMed ID: 27276215
[TBL] [Abstract][Full Text] [Related]
22. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Balan M; Chakraborty S; Flynn E; Zurakowski D; Pal S
Sci Rep; 2017 Jul; 7(1):5900. PubMed ID: 28724911
[TBL] [Abstract][Full Text] [Related]
23. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
24. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
25. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
[TBL] [Abstract][Full Text] [Related]
26. Honokiol inhibits HepG2 migration via down-regulation of IQGAP1 expression discovered by a quantitative pharmaceutical proteomic analysis.
Liang S; Fu A; Zhang Q; Tang M; Zhou J; Wei Y; Chen L
Proteomics; 2010 Apr; 10(7):1474-83. PubMed ID: 20127691
[TBL] [Abstract][Full Text] [Related]
27. Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway.
Bai Y; Chen B; Hong W; Liang Y; Zhou M; Zhou L
Oncol Rep; 2016 May; 35(5):2775-84. PubMed ID: 26987050
[TBL] [Abstract][Full Text] [Related]
28. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.
Luo H; Zhong Q; Chen LJ; Qi XR; Fu AF; Yang HS; Yang F; Lin HG; Wei YQ; Zhao X
J Cancer Res Clin Oncol; 2008 Sep; 134(9):937-45. PubMed ID: 18350317
[TBL] [Abstract][Full Text] [Related]
29. [Research progress in anticancer effects and molecular targets of honokiol in experimental therapy].
Chen SZ
Yao Xue Xue Bao; 2016 Feb; 51(2):202-7. PubMed ID: 29856535
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
31. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
Lee YS; Jeong S; Kim KY; Yoon JS; Kim S; Yoon KS; Ha J; Kang I; Choe W
Biochem Biophys Res Commun; 2021 May; 552():44-51. PubMed ID: 33743348
[TBL] [Abstract][Full Text] [Related]
32. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
Ling B; Liang SF; Xu YH; Zhao XY; Tang MH; Liu XY; Zhao X; Huang CH; Chen LJ; Wei YQ
Amino Acids; 2008 Jun; 35(1):115-22. PubMed ID: 18157584
[TBL] [Abstract][Full Text] [Related]
33. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.
Wolf I; O'Kelly J; Wakimoto N; Nguyen A; Amblard F; Karlan BY; Arbiser JL; Koeffler HP
Int J Oncol; 2007 Jun; 30(6):1529-37. PubMed ID: 17487375
[TBL] [Abstract][Full Text] [Related]
34. Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
Lv X; Liu F; Shang Y; Chen SZ
Oncol Rep; 2015 Sep; 34(3):1289-300. PubMed ID: 26136140
[TBL] [Abstract][Full Text] [Related]
35. Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Sun J; Li J; Liu Q; Jiang M; Yang M; Zhan S; Qiu T; He K; Zhang X
Eur J Pharm Sci; 2020 Apr; 146():105277. PubMed ID: 32105783
[TBL] [Abstract][Full Text] [Related]
36. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
Lv XQ; Qiao XR; Su L; Chen SZ
Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
[TBL] [Abstract][Full Text] [Related]
37. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
38. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells.
Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N
Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214
[TBL] [Abstract][Full Text] [Related]
39. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.
Suklabaidya S; Das B; Ali SA; Jain S; Swaminathan S; Mohanty AK; Panda SK; Dash P; Chakraborty S; Batra SK; Senapati S
Oncotarget; 2016 Jul; 7(27):41825-41842. PubMed ID: 27259232
[TBL] [Abstract][Full Text] [Related]
40. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
